The global diabetes market is experiencing exponential expansion driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading developers of GLP-1 receptor agonists, a https://phoenixfafh379032.59bloggers.com/37850238/leading-glp-1-manufacturers-innovation-in-diabetes-treatment